236 articles 4 sections last published 2026-08-31 independent · no sponsored placements

Fund index

NOBL

4 articles on this site analyse NOBL — 2 of them head-on.

Measured concentration

as of 2026-05-31
74 Holdings (nominal)
68.9 Effective holdings
1.1× Overstatement
16.54% Top 10 weight

NOBL reports 74 positions, but the weights make it behave like about 68.9 equally weighted ones. Computed by this site from the fund's SEC Form N-PORT filing — see what this measure does not tell you and the full table.

The same filing says what kind of price those positions carry: 99.96% of NOBL is held at a quoted market price, across 4 issuer countries . Comparisons across every fund are in the valuation table, and what a low share does and does not mean is worth reading before drawing a conclusion from it.

Every filing since 2019

27

Between 2019-11-30 and 2026-05-31, NOBL went from behaving like 57.1 equally weighted positions to 68.9 — 21% more, while its top ten went from 18.83% to 16.54% of net assets. Read across the funds on the concentration-over-time table.

PeriodHoldingsEffective Top 10Largest
2026-05-31 74 68.9 16.54% 1.76%
2026-02-28 79 68.7 16% 1.64%
2025-11-30 79 68.8 16.97% 2.02%
2025-08-31 76 69 15.88% 1.8%
2025-05-31 78 69 16.02% 1.66%
2025-02-28 76 68.8 16.1% 1.74%
2024-11-30 72 66 16.69% 1.81%
2024-08-31 74 66 16.54% 1.72%
2024-05-31 72 66.9 16.68% 1.83%
2024-02-29 72 67.1 16.26% 1.67%
2023-11-30 74 67.2 16.48% 1.73%
2023-08-31 73 66.3 16.41% 1.68%
2023-05-31 71 66.1 16.46% 1.77%
2023-02-28 73 67 16.81% 1.86%
2022-11-30 69 64.1 17.01% 1.78%
2022-08-31 72 63.8 17.66% 1.93%
2022-05-31 72 63.8 17.66% 2.09%
2022-02-28 69 64.9 17.84% 2.17%
2021-11-30 68 65.2 16.92% 1.84%
2021-08-31 70 65 17.13% 1.87%
2021-05-31 69 65 16.91% 1.98%
2021-02-28 70 65 17.23% 1.96%
2020-11-30 70 64.9 17.48% 2.06%
2020-08-31 69 65.1 16.67% 1.81%
2020-05-31 70 65.8 17.29% 1.89%
2020-02-29 69 64.2 17.02% 1.8%
2019-11-30 64 57.1 18.83% 2%

One row per filed reporting period, newest first, read from EDGAR. Quarterly because that is the public filing cadence. Rows marked * are published but held out of the comparison above; the methodology page says when and why.

Most often compared against

2

Measures applied to it

4

All articles

4

Mentions are detected across the full text of every article, so an appearance may be a passing comparison rather than the subject. Nothing here is a recommendation to buy or sell — see the disclaimer.